Glycogen Storage Disease Treated by Portacaval Transposition
Professor A G Riddell MBE MS FRCS and R P Davies MD FRCSE (Bristol Royal Infirmary, Bristol) Starzl has demonstrated in the dog that following a portacaval transposition the glycogen content of the liver falls. This led him to perform the operation on a child with glycogen storage disease, with encouraging results (Starzl et al. 1965) .
Clinical History
In September 1958 at the age of 6 months A M (now aged 7) was found to have an enlarged liver. Investigation revealed a fasting blood sugar of 30 mg/100 ml associated with a flat adrenaline glucose tolerance curve. Liver biopsy showed that the liver glycogen was increased to 22-9 g/100 g of tissue (normal 4-5 g/100 g of tissue). The structure of the glycogen was normal but there was a deficiency of glucose-6-phosphatase.
He was treated with a high protein diet and his fasting blood sugar increased to about 60 mg/100 ml. He had two convulsions associated with hypoglycwemia.
At the age of 7 years he was seen by Dr J Apley. He was then having severe recurrent upper respiratory tract infections, due to his grossly enlarged liver, and was physically and mentally underdeveloped. His electroencephalogram was abnormal. There was no family history of a similar disease. Operation at Bristol Royal Infirmary (7.5.65): During the period of clamping the vessels before the anastomosis the risk of venous congestion and injury to the bowel was reduced by cooling the patient to 28°C and by inserting a by-pass from superior vena cava to inferior vena cava.
Through a long right thoraco-abdominal incision the vessels were mobilized after elevation of the huge liver and ligation of many dilated lymphatic vessels.
The anastomosis was completed without any great tension. During the operation the temperature, blood pressure, upper and lower venous pressures were monitored.
The post-operative progress was complicated by chest infection, superimposed on an already impaired respiratory reserve and by septicaemia and jaundice. However, the child was discharged after three weeks. Progress: Six months after the operation there is a marked improvement in this boy's condition. Mentally he is more alert and is now attending a normal school: the EEG has reverted to normal. He has grown 2 in. in height in four months. He is taking a normal diet and has had no further hypoglyceemic symptoms.
Comment
Both in our case and in that reported by Starzl et al., a child treated for type III glycogen storage disease, there has been considerable benefit following portacaval transposition. Portacaval transposition was designed as an experimental procedure to study liver metabolism (Child et al. 1953) . The operation consists of division of the vena cava and the portal vein, the ends being then crossed over and anastomosed. The result is that blood from the gastro-intestinal tract passes into the systemic circulation and inferior vena caval blood passes directly into the liver. It is suggested that the intestinal blood with a high glucose content is delivered to the systemic circulation controlling the hypoglycemia. After operation the blood perfusing the liver has a low glucose content and this prevents the build up of glycogen stores. History: Normal motor development, but speech rather slower. From an early age he seemed to be short-sighted. At 4 years 4 months subluxated lenses were found and the diagnosis of Marfan's syndrome was suggested. Spectacles improved his vision. At 4 years 9 months, twenty-eight hours after a head injury without unconsciousness, he had a left-sided convulsion with loss of consciousness. After this he had attacks approximately weekly in which he looked vacant and might drop what he was holding, but never fell or jerked. At 6 years he had a second left-sided major convulsion with unconsciousness, lasting thirty minutes and followed by left-sided weakness for twenty-four hours. At 5 he had entered an ordinary school but made no progress. He was admitted for investigation at 6 years 4 months. On examination: Retarded, very timid boy with red malar skin and a suggestion of peripheral cyanosis. Palate high-arched. Head circumference 54 5 cm. Height and weight both just below 50th Optic discs normal. Bilateral dislocation of lenses, backwards, downwards and inwards. Marked iridodonesis bilaterally. Right convergent squint. Normal external ocular movements. Normal speech. Though strongly right-handed and tending to neglect the left hand, he could use the latter quite efficiently, and no weakness, sensory deficit, or difference in tone was detected. Tendon reflexes symmetrical and not increased. Abdominal reflexes symmetrical. Plantar responses flexor. Cardiovascular system normal. Blood pressure 110/70. Dorsal kyphosis. No other abnormality. Investigations: Hb 12-2 g/100 ml. Blood urea 28 mg/100 ml. Serum total protein 6-4 g/100 ml with normal electrophoretic pattern. Liver function tests: Serum bilirubin: total 0 9, conjugated 0-2, unconjugated 0 7 mg/100 ml. SGOT 80 and SGPT 52 pmoles pyruvate/100 ml serum/hour. Plasma alkaline phosphatase 17 K-A units/100 ml. Urine: no protein, deposit normal, culture sterile. Twenty-four-hour urine specimen: Sugars less than 5 mg/100 ml. Sodium nitroprusside test for cystine and homocystinestrongly positive. Amino-acid pattern showed the presence of homocystine and methionine. Electrochromatography of plasma amino acids showed a raised The amino-acid pattern given by the lysed red cells also showed a heavy spot due to methionine (Dr J Seakins).
REFERENCES
Plasma homocystine concentration 1 1 mg/100 ml (normally not detectable). Plasma methionine concentration 6-7 mg/100 ml (normal range 0-5-1-0 mg/100 ml) (Dr D C Cusworth).
Tryptophan loading test initially showed an abnormal ratio of 3 6.
Platelet Fig 1) : Vertebral bodies lack height relative to their other diameters. There is some biconcavity in the lower dorsal and lumbar regions. Knees (Fig 2) : Flaring of the metaphyses is present, with large bony epiphyses within large cartilaginous epiphyses. In these circumstances the irregularity of the distal femoral bony epiphyses is consider-d to be a result of the ossification occurring with growth. This irregularity is not seen in the proximal tibial epiphysis.
Harris's lines in the distal ends of the shafts are well marked. Hips: flaring of femoral necks with large femoral heads, otherwise normal. Hands and feet: bones within normal limits. No evidence of gross reduction in bone mineral content. EEG (Dr G Pampiglione): Severe generalized abnormality with almost continuous multifocal discharges. No clear lateralizing signs and no evidence of any recent cerebral catastrophe. ECG within normal limits. Psychometry: IQ 37 (Stanford-Binet). Mental level of below 32 months with Seguin Formboard test. His comparatively advanced manner of expression was possible evidence that he had once functioned at a higher level. Treatment: Anticonvulsant treatment consisted of primidone 100 mg b.d., and phenobarbitone 15 mg b.d. In view of the abnormal tryptophan test he was given pyridoxine 10 mg t.d.s. He was discharged on this treatment and readmitted six weeks later, having had no more convulsions, and vacant attacks limited to two or three per day. The tryptophan load test was now normal. The EEG showed no change. Repeat platelet function tests were again normal (27.5.65), and the platelet count was now within normal limits (255,000/c.mm).
Discussion
Since the recognition of homocystinuria in 1962 (Carson & Neill 1962 , Gerritsen et al. 1962 , Carson et al. 1963 ) the clinical picture has been delineated, with the usually low intelligence of the older child, malar flush, livedo reticularis of trunk and limbs, myopia, posterior dislocation of the lenses often with iridodonesis, and tendency to genu valgum, pectus excavatum and pes cavus. The boy described closely resembles this picture. The basic enzymatic defect is a deficiency or absence of cystathionine synthetase activity (Mudd et al. 1964 , Brenton et al. 1965 .
Several authors have noted resemblances clinically between homocystinuria and Marfan's syndrome (Gibson et al. 1964 , Carson et al. 1965 ). The last-named screened urine from many patients with ectopia lentis and/or presumed Marfan's syndrome, and found 36 cases of homocystinuria in 20 families. The ocular changes in the two conditions are very similar (McKusick 1965) . The cutaneous flushing and thrombotic tendency described by Komrower & Wilson (1963) in homocystinuria are features absent in Marfan's syndrome. Arachnodactyly is more apparent than real in homocystinuria. Marfan's syndrome is inherited as an autosomal dominant and homocystinuria probably as an autosomal recessive.
The tendency to spontaneous arterial and venous thrombosis in homocystinuria explains the risk of sudden death or morbidity following vascular accidents, often provoked by surgery. It is probably due partly to pathological changes in vessels (Gibson et al. 1964 but perhaps also to abnormal platelet function. McDonald et al. (1964) found increased platelet stickiness in four homocystinuric children despite normal platelet counts. However, Schimke et al. (1965) found normal platelet function, as did Dr Payling Wright in this case, in contrast with Dr Bray's first results. The X-ray changes in this patient are of doubtful significance and unlike those seen by Schimke and his colleagues, who found osteoporosis. Possibly this requires some years to develop and is thus not seen in young children. Dietary treatment: Theoretically a low-methionine, high-cystine diet might prevent the retardation, vascular lesions and lens dislocation, if not present at birth, in homocystinuria. By correcting abnormal platelet stickiness, it might also reduce the risk of thrombosis. A trial of cystine by Carson et al. (1963) did not prevent deterioration in one patient, but Komrower (1965, personal communication) has treated three patients with a low-methionine diet with apparently good results. The developmental history in homocystinuria often suggests a slowly progressive retardation, so that diet may need to be started early to be effective. It seems advisable to screen carefully all cases of ectopia lentis or presumed Marfan's syndrome so that early detection of homocystinuria may offer some hope of benefit from diet.
Dr C H C Upjohn said he had seen this child two years ago and had failed to make the right diagnosis. It had occurred to him at the time that this child was probably suffering from a metabolic disorder and a specimen of urine was sent to the local group laboratory for chromatography. The report stated that there was no abnormal amino-aciduria or sugar. Having received this report he virtually dismissed from his mind such a condition, which was clearly wrong. It seemed to him that the diagnosis had to be made on clinical grounds and a pathologist asked to look particularly for the specific metabolic disorder.
Dr George Komrower said that cases of homocystinuria had been missed in the past because most urine screenings had not included a chemical test for cystine. If this came up very strongly and then the amino-acid chromatogram contained an apparent cystine spot, homocystinuria should be included in the differential diagnosis together with disorders such as cystinosis, cystinuria and liver disease. The chromatogram appropriate for separating homocystine from cystine would then be done; the two overlapped in the ordinary chromatograms.
Dr Komrower suggested that the case under discussion merited dietary therapy, which he believed would help in the control of the epilepsy and might also prevent a further general deterioration in respect of the mental retardation, and of the bony and vascular changes found in this condition. Dr C L Bray said he had studied platelet stickiness in 11 patients with homocystinuria, in 10 of whom valid results were obtained using a modification (Slack et al. 1964) of Dr Payling Wright's method, but employing heparin 5 units/ml as anticoagulant; all the results were below the accepted normal range.
The investigations were repeated on several patients, and in the present case a less abnormal result was obtained on the second occasion. In patients with this condition there seemed to be more variation in platelet behaviour than in normal subjects. This might be associated with variations in the levels of homocystine and methionine, although information about this was not available. The abnormal platelet behaviour could be attributed to a toxic effect of methionine and homocystine as these amino acids and several structurally related substances produced abnormal platelet stickiness when added in vitro to the blood of healthy subjects, producing stickiness values comparable with those found in homocystinuria. It has been possible to define certain structure-action relationships and show that the presence of the red blood cells was essential to produce the effect. It was interesting that cystine shared this toxic property, and it was possible that cystine supplementation of the dief might not be without danger; in one of the early cases a cerebrovascular accident occurred during such treatment.
As to the differences in results obtained by different investigators studying platelet behaviour in this condition, even slight differences in technique, such as the preparation of glassware and the type and concentration of anticoagulant used, could make considerable differences to the results. This might explain the discrepancies, particularly those quoted by McKusick and his co-workers in their recent report .
The difference on repeated testing of individuals might be related to variations in blood levels of the amino acids and would support the contention that the abnormal platelet stickiness demonstrated in homocystinuria was attributable to a toxic effect of homocystine and methionine on the red cells, with consequent abnormalities of platelet behaviour. This might be a primary factor in the thrombotic tendency exhibited by these patients.
